Xvivo Financial Statements From 2010 to 2025
| XVIVO Stock | SEK 410.50 6.00 1.44% |
Check Xvivo Perfusion financial statements over time to gain insight into future company performance. You can evaluate financial statements to find patterns among Xvivo Perfusion's main balance sheet or income statement drivers, such as , as well as many indicators such as . Xvivo financial statements analysis is a perfect complement when working with Xvivo Perfusion Valuation or Volatility modules.
Xvivo |
Xvivo Perfusion AB Company Shares Outstanding Analysis
Xvivo Perfusion's Outstanding Shares are shares of common stock of a public company that were purchased by investors after they were authorized and issued by the company to the public. Outstanding Shares are typically reported on fully diluted basis, including exotic instruments such as options, or convertibles bonds.
Current Xvivo Perfusion Shares Outstanding | 29.83 M |
Most of Xvivo Perfusion's fundamental indicators, such as Shares Outstanding, are part of a valuation analysis module that helps investors searching for stocks that are currently trading at higher or lower prices than their real value. If the real value is higher than the market price, Xvivo Perfusion AB is considered to be undervalued, and we provide a buy recommendation. Otherwise, we render a sell signal.
Outstanding shares that are stated on company Balance Sheet are used when calculating many important valuation and performance indicators including Return on Equity, Market Cap, EPS and many others.
| Competition |
Based on the latest financial disclosure, Xvivo Perfusion AB has 29.83 M of shares currently outstending. This is 83.48% lower than that of the Health Care Equipment & Supplies sector and 82.95% lower than that of the Health Care industry. The shares outstanding for all Sweden stocks is 94.78% higher than that of the company.
Xvivo Perfusion AB Fundamental Drivers Relationships
Comparative valuation techniques use various fundamental indicators to help in determining Xvivo Perfusion's current stock value. Our valuation model uses many indicators to compare Xvivo Perfusion value to that of its competitors to determine the firm's financial worth. You can analyze the relationship between different fundamental ratios across Xvivo Perfusion competition to find correlations between indicators driving Xvivo Perfusion's intrinsic value. More Info.Xvivo Perfusion AB is rated first in return on equity category among its peers. It is rated first in return on asset category among its peers reporting about 0.42 of Return On Asset per Return On Equity. The ratio of Return On Equity to Return On Asset for Xvivo Perfusion AB is roughly 2.39 . The reason why the comparable model can be used in almost all circumstances is due to the vast number of multiples that can be utilized, such as the price-to-earnings (P/E), price-to-book (P/B), price-to-sales (P/S), price-to-cash flow (P/CF), and many others. The P/E ratio is the most commonly used of these ratios because it focuses on the Xvivo Perfusion's earnings, one of the primary drivers of an investment's value.About Xvivo Perfusion Financial Statements
Xvivo Perfusion shareholders use historical fundamental indicators, such as revenue or net income, to determine how well the company is positioned to perform in the future. Although Xvivo Perfusion investors may analyze each financial statement separately, they are all interrelated. The changes in Xvivo Perfusion's assets and liabilities, for example, are also reflected in the revenues and expenses on on Xvivo Perfusion's income statement. Understanding these patterns can help investors time the market effectively. Please read more on our fundamental analysis page.
Xvivo Perfusion AB , a medical technology company, provides solutions for organ, tissue, and cell preservation and perfusion in connection with transplantation. Xvivo Perfusion AB was founded in 1998 and is headquartered in Gothenburg, Sweden. Xvivo Perfusion operates under Medical Devices classification in Sweden and is traded on Stockholm Stock Exchange. It employs 45 people.
Thematic Opportunities
Explore Investment Opportunities
Additional Tools for Xvivo Stock Analysis
When running Xvivo Perfusion's price analysis, check to measure Xvivo Perfusion's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Xvivo Perfusion is operating at the current time. Most of Xvivo Perfusion's value examination focuses on studying past and present price action to predict the probability of Xvivo Perfusion's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Xvivo Perfusion's price. Additionally, you may evaluate how the addition of Xvivo Perfusion to your portfolios can decrease your overall portfolio volatility.